TrialStem cell research & therapy2017

CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia.

Shihong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.